|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A01K 67/027 | (2006.01) |
| C07K 14/74 | (2006.01) |
| (11) | Number of the document | 2967015 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14718815.5 |
| Date of filing the European patent application | 2014-03-11 | |
| (97) | Date of publication of the European application | 2016-01-20 |
| (45) | Date of publication and mention of the grant of the patent | 2023-06-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/023068 |
| Date | 2014-03-11 |
| (87) | Number | WO 2014/164638 |
| Date | 2014-10-09 |
| (30) | Number | Date | Country code |
| 201313793935 | 2013-03-11 | US |
| (72) |
MACDONALD, Lynn , US
MURPHY, Andrew J. , US
TU, Naxin , US
GURER, Cagan , US
VORONINA, Vera , US
STEVENS, Sean , US
|
| (73) |
Regeneron Pharmaceuticals, Inc. ,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (54) | TRANSGENIC MICE EXPRESSING CHIMERIC MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) CLASS II MOLECULES |
| TRANSGENIC MICE EXPRESSING CHIMERIC MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) CLASS II MOLECULES |